Allyx Therapeutics is a clinical-stage biotechnology company that develops therapies designed to reverse neurodegeneration.
Business Model:
Revenue: $0
Employees: 1-10
Address:
City: New Haven
State: New York
Zip:
Country: United States
Allyx Therapeutics is a clinical-stage biotechnology company that develops therapies designed to reverse neurodegeneration. Allyx Therapeutics&s; product is an orally bioavailable small molecule that acts as a silent allosteric modulator, enabling clinicians to get a drug that is capable of delivering a disease-modifying approach and preserve cognition in patients.
Contact Phone:
Contact Email:
Announced Date | Company | Transaction | Money Raised |
---|
Announced Date | Transaction | Number of Investors | Money Raised | Lead Investors | 1/2021 | Venture Round | 1 | - |
Life Science Angels Life Science Angels |
6/2021 | Venture Round | $7.6M | 4/2019 | Convertible Note | 1 | $230k |
Connecticut Innovations Connecticut Innovations |
1/2021 | Venture Round | 1 | - |
Life Science Angels Life Science Angels |
---|
Announced Date | Name | Price |
---|
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|